ÂÜÀòÂÒÂ×

Harry Loucks joins Circle Pharma as our Associate Director, Financial Planning and Analysis (FP&A). In his role, Harry is responsible for leading the organization’s FP&A function which includes responsibility for all corporate budgeting, planning, and management reporting, as well as driving strategic insights for the business. Before his time at Circle Pharma, Harry was at Astellas Gene Therapies where he was the Associate Director of FP&A for Research and Capital Finance. His responsibilities at Astellas included acting as the Finance business partner to the Gene Therapy Research organization which included leading the annual budget and quarterly forecast process, as well as providing monthly insights into actual performance. He was also responsible for capital expenditure planning and analysis. Prior to Astellas, Harry was an FP&A consultant at RGP, where he trained teams on FP&A best practices for forecasting, budgeting, planning, variance analysis and financial model building. Earlier in his career, Harry held various roles at Genentech/Roche where he provided FP&A, accounting, business intelligence and analytics leadership. Harry received his M.B.A. degree from Carnegie Mellon University and his B.S. in Pharmacy from The Ohio State University.